Clinical Trial Update: Promotora-based Latino Family CVD Risk Reduction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Promotora-based Latino family intervention for cardiovascular risk reduction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease

Snippet

Sponsor: University of California, Los Angeles | Conditions: Heart Disease, Cancer | Phase 2 | Status: COMPLETED